Keebeck Alpha, LP Haemonetics Corp Transaction History

Keebeck Alpha, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$71.24 - $85.35 $69,245 - $82,960	972 Added 31.08%	4,099 $349,000
Q4 2023 Feb 12, 2024	SELL	$80.59 - $92.61 $122,093 - $140,304	-1,515 Reduced 32.64%	3,127 $267,000
Q3 2023 Nov 02, 2023	BUY	$82.56 - $93.49 $186,172 - $210,819	2,255 Added 94.47%	4,642 $415,000
Q2 2023 Jul 25, 2023	BUY	$80.84 - $89.45 $192,965 - $213,517	2,387 New	2,387 $203,000
Q4 2020 Feb 05, 2021	SELL	$88.75 - $119.95 $288,437 - $389,837	-3,250 Closed	0 $0
Q3 2020 Nov 02, 2020	SELL	$75.65 - $93.58 $235,725 - $291,595	-3,116 Reduced 48.95%	3,250 $284,000
Q2 2020 Aug 06, 2020	BUY	$84.96 - $118.91 $218,262 - $305,479	2,569 Added 67.66%	6,366 $570,000
Q1 2020 May 06, 2020	SELL	$74.34 - $121.82 $8,920 - $14,618	-120 Reduced 3.06%	3,797 $378,000
Q4 2019 Feb 12, 2020	BUY	$114.37 - $129.46 $447,987 - $507,094	3,917 New	3,917 $450,000

333

54M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.39B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Keebeck Alpha, LP, based on Form 13F filings with the SEC.

Stay updated on Keebeck Alpha, LP with notifications on news.